Your browser doesn't support javascript.
loading
Application of implementation science for improving the utilization of an international clinical practice guidance on familial hypercholesterolemia.
Jones, Laney K; Gidding, Samuel S; Santos, Raul D; Libby, Peter; Watts, Gerald F; Sarkies, Mitchell N.
Afiliação
  • Jones LK; Department of Genomic Health, Geisinger, Danville, PA, USA (Drs Jones, Gidding); Heart and Vascular Institute, Geisinger, Danville, PA, USA (Dr Jones). Electronic address: Ljones14@geisinger.edu.
  • Gidding SS; Department of Genomic Health, Geisinger, Danville, PA, USA (Drs Jones, Gidding).
  • Santos RD; Lipid Clinic, Heart Institute (InCor), University of São Paulo, São Paulo, Brazil (Dr Santos); Hospital Israelita Albert Einstein, São Paulo, Brazil (Dr Santos).
  • Libby P; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's, Boston, MA, USA (Dr Libby); Harvard Medical School, Boston, MA, USA (Dr Libby).
  • Watts GF; School of Medicine, University of Western Australia, Perth, Western Australia, Australia (Dr Watts); Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia (Dr. Watts).
  • Sarkies MN; School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia (Dr Sarkies); Implementation Science Academy, Sydney Health Partners, University of Sydney, Sydney New South Wales, Australia (Dr Sarkies).
J Clin Lipidol ; 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-38910104
ABSTRACT

BACKGROUND:

The International Atherosclerosis Society (IAS) published an evidence-informed guidance for familial hypercholesterolemia (FH) that provides both clinical and implementation recommendations. We reference examples of strategies from the literature to explore how these implementation recommendations can be tailored into implementation strategies at the local-level for stakeholders guided by a framework proposed by Sarkies and Jones.

METHODS:

Four authors of the IAS guidance selected two published exemplar implementation recommendations for detection, management, and general implementation. Each recommendation was described as an implementation strategy using Proctor's guidance for specifying and reporting implementation strategies. It recommends reporting the actor (who), action (what), action-target (who is impacted), temporality (how often), and dose (how much) for each implementation strategy.

RESULTS:

Detection A centralized cascade testing model, mobilized nurses (actor) to relative's homes, after the diagnosis of the proband (temporality), once (dose) to consent, obtain a blood sample and health information (action) on relatives (action-target). MANAGEMENT A primary care initiative to improve FH management included an educational session (action) with clinicians (action-target), computer-based reminder message and message to patients to have their cholesterol screened once (dose) at a visit or outreach (temporality) by researchers (actor). General A partnership between a statewide public pathology provider, local public hospital network, primary health network, government health ministry, and an academic university (actors) was established to implement a primary-tertiary shared care model (action) to improve the detection of FH (action-target).

CONCLUSIONS:

We demonstrate that implementation recommendations can be specified and reported for different local contexts with examples on monitoring, evaluation, and sustainability in practice.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Lipidol Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Lipidol Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article